Literature DB >> 31493925

Physiological, Pathological, and Targetable Membraneless Organelles in Neurons.

Veronica H Ryan1, Nicolas L Fawzi2.   

Abstract

Neurons require unique subcellular compartmentalization to function efficiently. Formed from proteins and RNAs through liquid-liquid phase separation, membraneless organelles (MLOs) have emerged as one way in which cells form distinct, specialized compartments in the absence of lipid membranes. We first discuss MLOs that are common to many cell types as well as those that are specific to neurons. Interestingly, many proteins associated with neurodegenerative disease are found in MLOs, particularly in stress and transport granules. We next review possible links between neurodegeneration and MLOs, and the hypothesis that the protein and RNA inclusions formed in disease are related to the functional complexes occurring inside these MLOs. Finally, we discuss the hypothesis that protein post-translational modifications (PTMs), which can alter phase separation, can modulate MLO formation and provide potential new therapeutic strategies for currently untreatable neurodegenerative diseases.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  LLPS; RNA/RNP granule; membraneless organelle; neurodegeneration; post-translational modification

Mesh:

Year:  2019        PMID: 31493925      PMCID: PMC6779520          DOI: 10.1016/j.tins.2019.08.005

Source DB:  PubMed          Journal:  Trends Neurosci        ISSN: 0166-2236            Impact factor:   13.837


  107 in total

1.  A Liquid-to-Solid Phase Transition of the ALS Protein FUS Accelerated by Disease Mutation.

Authors:  Avinash Patel; Hyun O Lee; Louise Jawerth; Shovamayee Maharana; Marcus Jahnel; Marco Y Hein; Stoyno Stoynov; Julia Mahamid; Shambaditya Saha; Titus M Franzmann; Andrej Pozniakovski; Ina Poser; Nicola Maghelli; Loic A Royer; Martin Weigert; Eugene W Myers; Stephan Grill; David Drechsel; Anthony A Hyman; Simon Alberti
Journal:  Cell       Date:  2015-08-27       Impact factor: 41.582

Review 2.  The tip of the iceberg: RNA-binding proteins with prion-like domains in neurodegenerative disease.

Authors:  Oliver D King; Aaron D Gitler; James Shorter
Journal:  Brain Res       Date:  2012-01-21       Impact factor: 3.252

3.  Poly(GR) impairs protein translation and stress granule dynamics in C9orf72-associated frontotemporal dementia and amyotrophic lateral sclerosis.

Authors:  Yong-Jie Zhang; Tania F Gendron; Mark T W Ebbert; Aliesha D O'Raw; Mei Yue; Karen Jansen-West; Xu Zhang; Mercedes Prudencio; Jeannie Chew; Casey N Cook; Lillian M Daughrity; Jimei Tong; Yuping Song; Sarah R Pickles; Monica Castanedes-Casey; Aishe Kurti; Rosa Rademakers; Bjorn Oskarsson; Dennis W Dickson; Wenqian Hu; Aaron D Gitler; John D Fryer; Leonard Petrucelli
Journal:  Nat Med       Date:  2018-06-25       Impact factor: 53.440

Review 4.  Paraspeckles: Where Long Noncoding RNA Meets Phase Separation.

Authors:  Archa H Fox; Shinichi Nakagawa; Tetsuro Hirose; Charles S Bond
Journal:  Trends Biochem Sci       Date:  2017-12-27       Impact factor: 13.807

5.  Nuclear-Import Receptors Reverse Aberrant Phase Transitions of RNA-Binding Proteins with Prion-like Domains.

Authors:  Lin Guo; Hong Joo Kim; Hejia Wang; John Monaghan; Fernande Freyermuth; Julie C Sung; Kevin O'Donovan; Charlotte M Fare; Zamia Diaz; Nikita Singh; Zi Chao Zhang; Maura Coughlin; Elizabeth A Sweeny; Morgan E DeSantis; Meredith E Jackrel; Christopher B Rodell; Jason A Burdick; Oliver D King; Aaron D Gitler; Clotilde Lagier-Tourenne; Udai Bhan Pandey; Yuh Min Chook; J Paul Taylor; James Shorter
Journal:  Cell       Date:  2018-04-19       Impact factor: 41.582

6.  Increase of arginine dimethylation correlates with the progression and prognosis of ALS.

Authors:  Kensuke Ikenaka; Naoki Atsuta; Yasuhiro Maeda; Yuji Hotta; Ryoichi Nakamura; Kaori Kawai; Daichi Yokoi; Akihiro Hirakawa; Akira Taniguchi; Mitsuya Morita; Kouichi Mizoguchi; Hideki Mochizuki; Kazunori Kimura; Masahisa Katsuno; Gen Sobue
Journal:  Neurology       Date:  2019-03-13       Impact factor: 9.910

7.  ALS Mutations Disrupt Phase Separation Mediated by α-Helical Structure in the TDP-43 Low-Complexity C-Terminal Domain.

Authors:  Alexander E Conicella; Gül H Zerze; Jeetain Mittal; Nicolas L Fawzi
Journal:  Structure       Date:  2016-08-18       Impact factor: 5.006

8.  Residue-by-Residue View of In Vitro FUS Granules that Bind the C-Terminal Domain of RNA Polymerase II.

Authors:  Kathleen A Burke; Abigail M Janke; Christy L Rhine; Nicolas L Fawzi
Journal:  Mol Cell       Date:  2015-10-08       Impact factor: 17.970

9.  Phase transitions in the assembly of multivalent signalling proteins.

Authors:  Pilong Li; Sudeep Banjade; Hui-Chun Cheng; Soyeon Kim; Baoyu Chen; Liang Guo; Marc Llaguno; Javoris V Hollingsworth; David S King; Salman F Banani; Paul S Russo; Qiu-Xing Jiang; B Tracy Nixon; Michael K Rosen
Journal:  Nature       Date:  2012-03-07       Impact factor: 49.962

10.  Phase transition of a disordered nuage protein generates environmentally responsive membraneless organelles.

Authors:  Timothy J Nott; Evangelia Petsalaki; Patrick Farber; Dylan Jervis; Eden Fussner; Anne Plochowietz; Timothy D Craggs; David P Bazett-Jones; Tony Pawson; Julie D Forman-Kay; Andrew J Baldwin
Journal:  Mol Cell       Date:  2015-03-05       Impact factor: 17.970

View more
  35 in total

1.  Regulatory mechanisms of tau protein fibrillation under the conditions of liquid-liquid phase separation.

Authors:  Solomiia Boyko; Krystyna Surewicz; Witold K Surewicz
Journal:  Proc Natl Acad Sci U S A       Date:  2020-12-01       Impact factor: 11.205

Review 2.  Liquid-Liquid Phase Separation and Its Mechanistic Role in Pathological Protein Aggregation.

Authors:  W Michael Babinchak; Witold K Surewicz
Journal:  J Mol Biol       Date:  2020-03-10       Impact factor: 5.469

Review 3.  The (un)structural biology of biomolecular liquid-liquid phase separation using NMR spectroscopy.

Authors:  Anastasia C Murthy; Nicolas L Fawzi
Journal:  J Biol Chem       Date:  2020-01-07       Impact factor: 5.157

4.  Quality-control mechanisms targeting translationally stalled and C-terminally extended poly(GR) associated with ALS/FTD.

Authors:  Shuangxi Li; Zhihao Wu; Ishaq Tantray; Yu Li; Songjie Chen; Jason Dong; Steven Glynn; Hannes Vogel; Michael Snyder; Bingwei Lu
Journal:  Proc Natl Acad Sci U S A       Date:  2020-09-21       Impact factor: 11.205

5.  Weak binding to the A2RE RNA rigidifies hnRNPA2 RRMs and reduces liquid-liquid phase separation and aggregation.

Authors:  Veronica H Ryan; Scott Watters; Joshua Amaya; Balabhadra Khatiwada; Vincenzo Venditti; Mandar T Naik; Nicolas L Fawzi
Journal:  Nucleic Acids Res       Date:  2020-10-09       Impact factor: 16.971

6.  Pharmacological inhibition of DEAD-Box RNA Helicase 3 attenuates stress granule assembly.

Authors:  B Celia Cui; Vitali Sikirzhytski; Marina Aksenova; Matthew D Lucius; Gabrielle H Levon; Zachary T Mack; Charlotte Pollack; Diana Odhiambo; Eugenia Broude; Sofia B Lizarraga; Michael D Wyatt; Michael Shtutman
Journal:  Biochem Pharmacol       Date:  2020-10-10       Impact factor: 5.858

Review 7.  RNA-binding proteins in neurological development and disease.

Authors:  Shavanie Prashad; Pallavi P Gopal
Journal:  RNA Biol       Date:  2020-08-30       Impact factor: 4.652

8.  A predictive coarse-grained model for position-specific effects of post-translational modifications.

Authors:  Theodora Myrto Perdikari; Nina Jovic; Gregory L Dignon; Young C Kim; Nicolas L Fawzi; Jeetain Mittal
Journal:  Biophys J       Date:  2021-02-12       Impact factor: 4.033

Review 9.  Post-translational Control of RNA-Binding Proteins and Disease-Related Dysregulation.

Authors:  Alejandro Velázquez-Cruz; Blanca Baños-Jaime; Antonio Díaz-Quintana; Miguel A De la Rosa; Irene Díaz-Moreno
Journal:  Front Mol Biosci       Date:  2021-04-27

Review 10.  The Integral Role of RNA in Stress Granule Formation and Function.

Authors:  Danae Campos-Melo; Zachary C E Hawley; Cristian A Droppelmann; Michael J Strong
Journal:  Front Cell Dev Biol       Date:  2021-05-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.